FluoroquinolonesAnti-Infective AgentsCiprofloxacinOfloxacinDNA GyraseAza CompoundsLevofloxacinMicrobial Sensitivity TestsDNA Topoisomerase IVAnti-Bacterial AgentsNorfloxacinQuinolonesDrug Resistance, BacterialChemistry, PharmaceuticalPefloxacinNaphthyridinesQuinolinesEnoxacinDrug Resistance, Microbial4-QuinolonesDrug Resistance, Multiple, BacterialDNA Topoisomerases, Type IIStreptococcus pneumoniaeDermatitis, PhototoxicDrug CompoundingExcipientsDelayed-Action PreparationsTabletsNalidixic AcidTopoisomerase II InhibitorsGram-Negative Bacterial InfectionsDosage FormsMacrolidesDrug CarriersStaphylococcus aureusFleroxacinMycoplasma hominisTechnology, PharmaceuticalPneumococcal Infectionsbeta-LactamsBacterial InfectionsMutationClostridium difficileEscherichia coliEmulsionsDrug StabilityTyphoid FeverMycobacterium fortuitumGram-Negative BacteriaPseudomonas aeruginosaNitrofurantoinAdministration, OralArea Under CurveAminoglycosidesDNA, BacterialTherapeutic EquivalencyCapsulesAntitubercular AgentsGram-Positive BacteriaDrug Resistance, MultipleParticle SizeCapreomycinCommunity-Acquired InfectionsDrug UtilizationBacterial ProteinsUrinary Tract InfectionsPowdersBiological AvailabilityDrug Delivery SystemsEscherichia coli InfectionsSolubilityAdministration, TopicalEnterocolitis, PseudomembranousPharmaceutical SolutionsParatyphoid FeverCephalosporinsNeisseria gonorrhoeaeCross InfectionAnti-Infective Agents, UrinarySkin AbsorptionNanoparticlesMethylcelluloseSalmonella typhiLaurusMycobacterium tuberculosisBartonella bacilliformisGram-Positive Coccibeta-LactamasesLiposomesCampylobacterMoraxella (Branhamella) catarrhalisGram-Positive Bacterial InfectionsPharmaceutical VehiclesChromatography, Supercritical FluidRespiratory Tract InfectionsOtitis ExternaGonorrheaKlebsiella pneumoniaeSalmonella paratyphi ASalmonella enterica